Ho Jung An, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Myung Ah Lee, Young Kyoung You, Dong Goo Kim, Eun Sun Jung – 23 July 2012 – Liver transplantation (LT) is a curative modality for hepatocellular carcinoma (HCC), especially in patients with cirrhosis. However, there are still risks of recurrence. C‐reactive protein (CRP), an acute‐phase inflammatory reactant that is synthesized by hepatocytes, has been related to the prognosis of various malignancies, including HCC.

Nezam H. Afdhal – 23 July 2012 – Watch a video presentation of this article

John Rice, Lisa Cervantes, Michael R. Lucey – 23 July 2012 – Watch the interview with the authors

John Rice, Lisa Cervantes, Michael R. Lucey – 23 July 2012 – Watch the interview with the authors

Sanjeev Arora, Karla Thornton, Andrea Bradford – 23 July 2012 – Watch a video presentation of this article

Diana L. Sylvestre – 23 July 2012 – Watch an interview with the author

Andres F. Carrion, Paul Martin – 23 July 2012 – Watch the interview with the authors

Ho‐Geol Ryu, Chul‐Woo Jung, Hyung‐Chul Lee, Youn‐Joung Cho – 23 July 2012 – Acute hypotension after reperfusion of the liver graft occurs frequently during liver transplantation. A randomized, prospective trial was performed to test the effects of epinephrine and phenylephrine pretreatments for attenuating postreperfusion syndrome (PRS). Ninety‐three adult liver recipients were randomly allocated to receive an intravenous bolus of 10 μg of epinephrine, 100 μg of phenylephrine, or normal saline (the control group) at the time of graft reperfusion.

Michael J. Englesbe – 23 July 2012

Wolfram Goessling – 23 July 2012